Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion type Assertion NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_head.
- NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion description "[In B-cell non-Hodgkin's lymphoma (NHL), as in other B-cell malignancies, clonal rearrangement of the third complementarity determining region (CDR III) of the immunoglobulin heavy chain gene (IgH) provides a useful marker for the detection of minimal residual disease (MRD) after treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_provenance.
- NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion evidence source_evidence_literature NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_provenance.
- NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion SIO_000772 8896395 NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_provenance.
- NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion wasDerivedFrom befree-20140225 NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_provenance.
- NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_assertion wasGeneratedBy ECO_0000203 NP913372.RAPDbWeYqz5mh_3Bz5xtSimUMUDyKz3MPdm_Znpp5kJ0w130_provenance.